MARKET

ANEB

ANEB

Anebulo Pharmaceuticals Inc
OTCPK
0.336
NaN%
Closed 09:30 07/17 EDT
OPEN
--
PREV CLOSE
0.336
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.420
52 WEEK LOW
0.310
MARKET CAP
13.72M
P/E (TTM)
-1.7322
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ANEB last week (0706-0710)?
Weekly Report · 4d ago
Weekly Report: what happened at ANEB last week (0629-0703)?
Weekly Report · 07/06 09:36
Weekly Report: what happened at ANEB last week (0622-0626)?
Weekly Report · 06/29 09:33
Weekly Report: what happened at ANEB last week (0615-0619)?
Weekly Report · 06/22 09:37
Weekly Report: what happened at ANEB last week (0608-0612)?
Weekly Report · 06/15 09:38
Weekly Report: what happened at ANEB last week (0601-0605)?
Weekly Report · 06/08 09:36
Weekly Report: what happened at ANEB last week (0525-0529)?
Weekly Report · 06/01 09:38
Weekly Report: what happened at ANEB last week (0518-0522)?
Weekly Report · 05/25 09:40
More
About ANEB
Anebulo Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is developing treatments for cannabis-induced toxicity, such as acute cannabis-induced toxicity in children, acute cannabinoid intoxication (ACI) in adults, and the landscape of acute cannabis-induced conditions. Its lead product candidate, selonabant (formerly ANEB-001), has completed a Phase II clinical trial evaluating its utility in blocking and reversing the negative effects of ACI in healthy adults challenged with oral tetrahydrocannabinol. Selonabant is orally bioavailable, absorbed, and has also been formulated for intravenous administration. Selonabant is intended to reverse the negative effects of cannabis-induced toxicity and reduce time to recovery. It is also focused on the advancement of a selonabant IV formulation as a potential treatment for pediatric patients with acute cannabis-induced toxicity. Selonabant is a competitive antagonist at the human cannabinoid receptor type-1 receptor.

Webull offers Anebulo Pharmaceuticals Inc stock information, including OTCPK: ANEB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANEB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANEB stock methods without spending real money on the virtual paper trading platform.